News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ARC Capital Invests $13 Million in Buchang Pharma



7/6/2011 1:21:45 PM

July 5, 2011 -- ARC Capital Holdings of Hong Kong paid $13 million to acquire a minority interest in Buchang Pharmaceutical Group, a privately-owned TCM company. According to a news release, Buchang is the largest TCM company in China – if the judging standard is net profit. Buchang, which was founded in 1993, includes two hospitals and a university in addition to its portfolio of six pharma entities. More details....

Stock Symbol: (AIM: ARCH)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES